Workforce & Economy: MOM reports Q1 2026 retrenchments rose to 3,830, with degree holders and older workers hit harder as restructuring continues in manufacturing, financial services and professional services. Precision Health: ASTAR Genome Institute study links gut microbes to liver gene control via active DNA “switches,” pointing to more targeted liver-disease diagnostics and therapies. Dengue Response: Six regional groups, including the Singapore Dengue Alliance, sign an MOU to coordinate knowledge-sharing and action as dengue spreads faster across Asia. Medical Innovation: Cuprina gets U.S. FDA 510(k) clearance for MEDIFLY Maggots for debridement of non-healing wounds, while IHLD MedTech plans more wound-care centres in India with $3m initial funding from UltraGreen.ai. Local Health Tech & Care: Foundation Healthcare says it plans a Singapore IPO prospectus soon, aiming to raise up to $500m. Digital Health & Governance: ASTAR and NUS launch a synthetic biology commercialisation lab, and Singapore-based Mirxes expands cancer blood-test quality processes after ISO 13485 certification. Business & Wellness Adjacent: Allianz is said to lead bidding for HSBC Life Singapore, signalling continued demand for protection and life/health products.